Medpace Holdings, Inc. (MEDP) Share buybacks
- Total buybacks · last 12 months (USD): Value $299.34M; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $299.34M | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 299.34M USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $299.34M | (m) | (m) |
| 2026-03-31 | $545.49M | (m) | (m) |
| 2025-12-31 | $917.39M | (m) | (m) |
| 2025-09-30 | $1.09B | (m) | (m) |
| 2025-06-30 | $1.08B | (m) | (m) |
| 2025-03-31 | $541.77M | (m) | (m) |
| 2024-12-31 | $169.87M | (m) | (m) |
| 2024-09-30 | $0.00 | (m) | (m) |
| 2024-06-30 | $0.00 | (m) | (m) |
| 2024-03-31 | $23.87M | (m) | (m) |
| 2023-12-31 | $144.02M | (m) | (m) |
| 2023-09-30 | $191.20M | (m) | (m) |
| 2023-06-30 | $191.20M | (m) | (m) |
| 2023-03-31 | $542.04M | (m) | (m) |
| 2022-12-31 | $847.85M | (m) | (m) |
| 2022-09-30 | $800.67M | (m) | (m) |
| 2022-06-30 | $806.89M | (m) | (m) |
| 2022-03-31 | $488.05M | (m) | (m) |
| 2021-12-31 | $62.10M | (m) | (m) |
| 2021-09-30 | $109.54M | (m) | (m) |
| 2021-06-30 | $103.32M | (m) | (m) |
| 2021-03-31 | $56.50M | (m) | (m) |
| 2020-12-31 | $98.27M | (m) | (m) |
| 2020-09-30 | $50.83M | (m) | (m) |
| 2020-06-30 | $50.83M | (m) | (m) |
| 2020-03-31 | $41.78M | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2019-09-30 | $0.00 | (m) | (m) |
| 2019-06-30 | $0.00 | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | (m) | (m) |
| 2018-09-30 | $60.32M | (m) | (m) |
| 2018-06-30 | $129.18M | (m) | (m) |
| 2017-12-31 | $155.58M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |